12 Health Care Stocks Moving In Wednesday's Intraday Session

Author: Benzinga Insights | May 17, 2023 01:31pm

Gainers

• Immutep (NASDAQ:IMMP) stock rose 141.2% to $3.83 during Wednesday's regular session. Immutep's stock is trading at a volume of 53.7 million shares as of 13:30 EST. This is 57503.7% of its average full-day volume over the last 100 days. The company's market cap stands at $337.2 million.
• Motus GI Hldgs (NASDAQ:MOTS) stock moved upwards by 37.22% to $0.99. Motus GI Hldgs's stock is trading at a volume of 14.7 million shares as of 13:30 EST. This is 44159.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.7 million.
• Viracta Therapeutics (NASDAQ:VIRX) shares increased by 36.54% to $1.7. The current volume of 1.3 million shares is 1652.3% of Viracta Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $65.2 million.
• Rigel Pharmaceuticals (NASDAQ:RIGL) stock rose 31.0% to $1.69. The current volume of 8.1 million shares is 305.2% of Rigel Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $293.4 million.
• Corvus Pharma (NASDAQ:CRVS) stock increased by 28.27% to $3.04. The current volume of 3.1 million shares is 589.4% of Corvus Pharma's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $141.5 million.
• X4 Pharmaceuticals (NASDAQ:XFOR) stock moved upwards by 23.86% to $2.18. As of 13:30 EST, X4 Pharmaceuticals's stock is trading at a volume of 8.6 million, which is 377.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $266.4 million.

Losers

• Mallinckrodt (AMEX:MNK) shares declined by 15.3% to $1.6 during Wednesday's regular session. Mallinckrodt's stock is trading at a volume of 80.6K shares as of 13:30 EST. This is 200.0% of its average full-day volume over the last 100 days. The company's market cap stands at $21.0 million.
• Citius Pharma (NASDAQ:CTXR) shares fell 15.2% to $1.06. The current volume of 3.7 million shares is 298.0% of Citius Pharma's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $168.3 million. As per the news, the Q2 earnings report came out 3 days ago.
• Intercept Pharma (NASDAQ:ICPT) stock decreased by 14.47% to $13.87. Trading volume for this security as of 13:30 EST is 4.4 million, which is 576.0% of its average full-day volume over the last 100 days. The company's market cap stands at $577.9 million.
• TScan Therapeutics (NASDAQ:TCRX) stock declined by 12.54% to $3.49. As of 13:30 EST, TScan Therapeutics's stock is trading at a volume of 182.5K, which is 13.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $84.5 million.
• Cyclacel Pharmaceuticals (NASDAQ:CYCCP) stock declined by 11.6% to $9.8.
• Venus Concept (NASDAQ:VERO) stock decreased by 11.27% to $2.52. The company's market cap stands at $13.4 million. As per the news, the Q1 earnings report came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: CRVS CTXR CYCCP ICPT IMMP MNK MOTS RIGL TCRX VERO VIRX XFOR